Sally E. Blount

CIK: 0001537286

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ABT

ABBOTT LABORATORIES

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

ABT
ABBOTT LABORATORIES
Apr 24, 2026
Award(A)
Direct
2.3K shares-
ABT
ABBOTT LABORATORIES
Apr 30, 2025
Sale(S)
Direct
2.6K shares at avg. $129.66$337K
ABT
ABBOTT LABORATORIES
Apr 25, 2025
Award(A)
Direct
1.6K shares-

		Type	Shares	Price		Ownership
Apr 24, 2026	ABT ABBOTT LABORATORIES	Award(A)	2,286	-	$0	Direct
Apr 30, 2025	ABT ABBOTT LABORATORIES	Sale(S)	2,600	$129.66	$337,116	Direct
Apr 25, 2025	ABT ABBOTT LABORATORIES	Award(A)	1,635	-	-	Direct

1-3 of 3 transactions

About Blount Sally E.

Blount Sally E. (SEC CIK 0001537286) files insider reports with the SEC as Director of ABBOTT LABORATORIES (ABT).

Signal8 holds 3 ownership filings by Blount Sally E., all Form 4s, filed between Apr 29, 2025 and Apr 28, 2026. Those filings report 3 transactions, from Apr 25, 2025 to Apr 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Blount Sally E.'s filings is in ABBOTT PARK, IL.

Recent filings by Blount Sally E.

Apr 24, 2026: Grant or award of ABT shares (Form 4, code A).
Apr 30, 2025: Open-market sale of ABT shares (Form 4, code S).
Apr 25, 2025: Grant or award of ABT shares (Form 4, code A).

Other insiders filing for ABBOTT LABORATORIES (ABT)

Stratton John G, Director
Gonzalez Patricia Paola, Director
Conroy Kevin T, Director
Ahuja Nita, Director
Roman Michael F, Director
MCCOY JOHN A. JR., VICE PRESIDENT AND CONTROLLER

How to read Form 4 transaction codes